Drug Type Small molecule drug |
Synonyms 원라인세미정 |
Mechanism A1R agonists(Adenosine A1 receptor agonists), A2aR antagonists(Adenosine A2a receptor antagonists), Adenosine receptor antagonists + [3] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date KR (19 Sep 2024), |
Regulation- |
Molecular FormulaC10H15NO |
InChIKeyKWGRBVOPPLSCSI-WPRPVWTQSA-N |
CAS Registry299-42-3 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Common Cold | KR | 19 Sep 2024 |